Glaukos Corporation (6GJ)
XDUS
Real-time Data
06:00 AM
Day's Range
154.0052 wk Range
62.50Overview - 6GJ - Glaukos Corporation
Key Statistics
Valuation
P/E (Trailing)
‪-47.56‬
PEG Ratio
‪5.39‬
Price / Book
‪13.44‬
Profitability
Gross Margin
‪81.67%‬
Profit Margin
‪55.72%‬
Operating Margin
‪-37.12%‬
Return on Assets
‪-21.00%‬
Return on Equity
‪-28.60%‬
Ownership
Shares Outstanding
58.85M
Price stats
50-Day Avg
‪134.90‬
200-Day Avg
‪107.03‬
Peers - 6GJ - Glaukos Corporation
Peer Comparison
Compared with companies in Medical Devices listed on XDUS.
- 6GJXDUSGlaukos Corporation+50.00%52-week change-48.17P/E (Trailing)‪55.72%‬Profit Margin
- PENXDUSPBF Energy Inc.+66.09%52-week change-43.73P/E (Trailing)‪-1.94%‬Profit Margin
- 8HHXDUSAvanos Medical Inc.+53.94%52-week change-13.76P/E (Trailing)‪50.47%‬Profit Margin
- CU2XDUSCerus Corporation+53.91%52-week change-28.75P/E (Trailing)‪54.47%‬Profit Margin
- 3L3XDUSTactile Systems Technology Inc.+45.05%52-week change24.12P/E (Trailing)‪75.91%‬Profit Margin
- 4ZGXDUSMedian Technologies S.A.+44.08%52-week change-4.86P/E (Trailing)‪102.97%‬Profit Margin
- 3E0XDUSEstablishment Labs Holdings Inc.+42.77%52-week change-35.97P/E (Trailing)‪69.31%‬Profit Margin
Profile Summary - 6GJ - Glaukos Corporation
About
Glaukos Corporation is a medical technology company dedicated to the development and commercialization of innovative products for the treatment of glaucoma, corneal disorders, and retinal diseases. Its primary function is to address the substantial unmet medical needs present in ophthalmic healthcare. Glaukos is…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
